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Background:  A decreased lumbosacral subarachnoidal space volume is a major factor in the cephalad intrathecal 
spread of local anesthetics in term parturients and their subarachnoidal space is decreased due to the compressive 
effect of huge uteri.  Therefore, they show a higher level of sensory block and hypotensive episodes.  The purpose of 
this study is to investigate whether the symphysis-fundal height (SFH) correlates with the highest sensory level and 
the amount of ephedrine administered under spinal anesthesia.
Methods:  Fifty-two uncomplicated parturients who consented to spinal anesthesia for elective cesarean section 
were studied.  The SFH of all parturients had been measured just before the spinal anesthesia administered by one 
person.  Hyperbaric bupivacaine with fentanyl 20 μg, was administered for spinal anesthesia. The amount of 0.5% 
bupivacaine was adjusted according to the patient’s height and weight.  The level of sensory block and the amounts of 
ephedrine to treat hypotension, nausea and vomiting were assessed. Linear regression and correlation analysis were 
applied to analyze the data.
Results:  According to the results of correlation analysis, there was no significant correlation between the level of 
sensory block and SFH.  There were statistically significant positive correlations between the amount of ephedrine 
administered due to hypotension and SFH.
Conclusions:  In term parturients choosing elective cesarean section, the SFH is not correlated with the sensory level 
of spinal anesthesia, but is correlated with the amount of ephedrine administered during spinal anesthesia.  (Korean 
J Anesthesiol 2010; 59: 173-178)
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Introduction
    Spinal anesthesia is one of the most preferred anesthetic 
methods during Cesarean section since it provides easy and 
rapid induction, effective sensory and motor block and has 
little effect on the fetus [1]. However, in a parturient woman, 
the lumbosacral subarachnoidal space volume is decreased 
as the inferior vena cava is pressed by the hypertrophic uterus 
and plexus venosus collateral circulation is developed in the 
epidural space. Because of this, the amount of cerebrospinal 
fluid is decreased in the lumbosacral area and the small dose 
of administrated local anesthetic moves mainly to the cranial 
cavity; consequently, the incidents of high spinal anesthesia 
and hypotension increase [2,3]. In order to reduce the risk of 
high spinal anesthesia, studies have been conducted regarding 
factors that affect the level of anesthesia, such as height, weight 
and body mass index (BMI), but the roles of these factors 
are controversial. Norris [4] reported that height, weight and 
BMI are not related to the level of spinal anesthesia during 
Cesarean section. However, in a recent study, Harten et al. [5] 
reported that when the local anesthetic dose is administrated 
considering the height and weight of parturient women, 
hypotension incidents are reduced compared to the cases 
reported using a fixed dose. However, we have observed that 
a considerable number of incidents of hypotension, nausea 
and vomiting were found, even in the cases where the local 
anesthetic dose was administrated under consideration of 
the height and weight of the parturient women who were 
supposed to undergo Cesarean section. In this study, therefore, 
we investigated whether the symphysis-fundal height (SFH) is 
related to the sensory block level, the ephedrine dose according 
to incidence of hypotension, nausea, and vomiting.
Materials and Methods
    The study subjects were 52 parturient women whose American 
Society of Anesthesiologist physical status class was Class 1 or 
Class 2, among patients in the 38th to 42nd week of pregnancy 
who were supposed to undergo Cesarean section. The pregnant 
women who had contraindication for spinal anesthesia, 
e.g., those who displayed gestational hypertension, placenta 
previa, twin pregnancy, uterine myoma, oligohydramnios 
or hydramnion; those whose weight was less than 50 kg or 
more than 100 kg; those whose height was less than 140 cm or 
more than 180 cm; and those who were converted to general 
anesthesia due to insufficient spinal anesthesia, were excluded 
from the study. All the study patients were given an explanation 
about the purpose of the study prior to anesthesia, and they 
consented to the study. The study was permitted by the 
Institutional Review Board of the hospital.
    For all the parturient women, an automated noninvasive 
blood pressure device was installed on the right arm and a 
pulse oximetry and electrocardiograph were installed on the left 
arm prior to spinal anesthesia, in order to record blood pressure 
and heart rate. The initially measured blood pressure and heart 
rate were defined as the resting blood pressure and resting 
heart rate. During the intravenous injection of Hartmann 
crystalloid solution (15 ml/kg), the SFH was measured by a 
single person who palpated the edge of the uterine fundus 
from the superior edge of the pubic symphysis of the pregnant 
women, who were in the spine position on a table that was 
adjusted to be horizontal (Fig. 1). The height was not revealed to 
the anesthetist. Following 20 minutes of intravenous injection 
of the Hartmann crystalloid solution, the parturient women 
were converted to the right lateral recumbent position. Dural 
puncture was performed with a 26 G Quincke needle in a 
midline approach after disinfecting the puncture area between 
the L3-L4 lumbar vertebrae. After checking the cerebrospinal 
fluid outflow, the drug was injected at the rate of 0.1 ml/sec 
without changing the direction of the bevel. Regarding the dose 
Table 1. Adjusted Dose Regimen for 0.5% Hyperbaric Bupivacaine 
when Used for Spinal Anesthesia for Cesarean Section (ml)
Weight 
(kg)
Height (cm)
140 145 150 155 160 165 170 175 180
 50
 55
 60
 65
 70
 75
 80
 85
 90
95
100
105
110
1.5
1.5
1.4
1.4
1.3
1.7
1.6
1.6
1.5
1.5
1.4
1.4
1.8
1.8
1.7
1.7
1.6
1.6
1.5
1.5
1.4
1.9
1.9
1.8
1.8
1.8
1.7
1.7
1.6
1.6
1.5
1.5
2.0
2.0
1.9
1.9
1.9
1.8
1.8
1.7
1.7
1.7
1.6
2.1
2.1
2.0
2.0
2.0
1.9
1.9
1.8
1.8
1.7
1.7
2.2
2.2
2.1
2.1
2.1
2.0
2.0
1.9
1.9
1.8
2.3
2.3
2.2
2.2
2.2
2.1
2.1
2.0
2.0
2.4
2.4
2.3
2.3
2.3
2.2
2.2
2.2 Fig. 1. Measurement of the symphysis-fundal height.175 www.ekja.org
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of the drug, fentanyl 20 μg was mixed with the hyperbaric 0.5% 
bupivacaine (Bupivacaine HCl
Ⓡ, Myungmoon Pharmaceuticals, 
Korea) dose (Table 1) that was determined by considering the 
height and weight of the patients, as suggested by Harten et al. 
[5], and the mixture was injected. Immediately after injecting 
the drug, the patients took the spine position and the uterus 
was transposed to the left by tilting the table by 15
o to the left, in 
order to prevent supine hypotensive syndrome. For the sensory 
nerve block, a cold feeling examination was performed with 
an alcohol swab every one minute, from the umbilicus and 
epigastric region to the center of the neck along the midline 
of the parturient women, until the height did not change any 
more; this was done to determine the maximum sensory 
blockade level. After completing the drug injection through 
the subarachnoid space, the blood pressure was measured 
every 2 minutes. When the systolic blood pressure dropped 
below 100 mmHg, or decreased by more than 20% of the resting 
blood pressure, or when the parturient women complained of 
nausea and vomiting, ephedrine (Ephedrine HCl
Ⓡ, Daewon 
Pharmaceuticals, Korea) (4 mg) was intravenously injected. 
When the blood pressure drop continued after the blood 
pressure measurement in 2-minute intervals, the same dose 
was repeatedly injected. Oxygen was supplied at the rate of 
5 l/min through the face mask to all the parturient women. 
The operation was initiated after adjusting the table to be 
horizontal when the maximum sensory blockade level of the 
spinal anesthesia was T6 or higher and the blood pressure 
and heart rate of the parturient women became stable. 
Intravenous injection of fentanyl (80 μg) was carried out when 
the patients complained of visceral pain during the operation 
or the spinal anesthesia was converted to general anesthesia 
when the injection was considered inappropriate. The weight 
of the newborn baby was recorded after the delivery. The side 
effects such as hypotension, nausea and vomiting, respiratory 
depression or pruritus were observed and recorded.
    All the measurements were presented as “mean ± standard 
deviation” and the SAS
Ⓡ Enterprise Guide fourth edition 
was used. Correlation analysis was performed to find the 
correlations among the SFH, ephedrine dose, and the 
maximum sensory blockade level.
    The correlation between the SFH and the administrated 
ephedrine dose and the correlation between the weight of 
the fetus and the administrated ephedrine dose were also 
investigated. The regression equations (y = ax + b) were obtained 
for the SFH, the administrated ephedrine dose, and the weight 
of the fetus, respectively, by using the linear regression method, 
and the coefficients of determination (r
2) were compared.
Results
    The subjects for this study were 52 parturient women within 
the age range of 32.7 ± 4.3, the weight of 68.4 ± 8.8 kg, and the 
height of 158.4 ± 5.4 cm. The weight of the fetuses was 3252.7 
± 405.5 g; the SFH of the parturient women was 39.6 ± 2.4 cm; 
the hyperbaric 0.5% bupivacaine dose that was injected during 
the spinal anesthesia was 9.5 ± 0.6 mg; and the ephedrine dose 
administrated after the spinal anesthesia was 7.5 ± 9.8 mg (Table 2).
    The maximum sensory blockade level of the spinal anesthesia 
was T4 for 24 patients, T5 for 2 patients, and T6 for 26 patients. 
None of the parturient women in the supine position showed 
supine hypotensive syndrome before the spinal anesthesia 
for Cesarean section and there was no case which required 
converting to general anesthesia due to inappropriate spinal 
anesthesia. Ephedrine was injected to treat the hypotension, 
nausea and vomiting after the spinal anesthesia in 28 of the 
52 cases (53.8%), and of the 28 cases, nausea and vomiting 
accompanied 17 of them. In 6 out of the 52 cases (11.5%), 
fentanyl was additionally administrated for visceral pain. None 
of the parturient women complained of respiratory depression 
after the spinal anesthesia or of nausea and vomiting in the 
postoperative recovery room. However, pruritus occurred in 1 
out of the 52 parturient women (0.02%) (Table 3).
    The correlation analysis result showed that the correlation 
coefficient between the maximum sensory blockade level and 
the SFH was - 0.195 and the significance test of the correlation 
coefficient showed that the P value was 0.165, which means 
Table 2. Demographic Data
N = 52
Age (yr)
Height (cm)
Weight (kg)
Baby weight (g)
SFH (cm)
0.5% Bupivacaine dose (mg)
Ephedrinedose (mg)
 32.7 ± 4.3
158.4 ± 5.4
 68.4 ± 8.8
 3252.7 ± 405.5
 39.6 ± 2.4
   9.5 ± 0.6
   7.5 ± 9.8
Values are mean ± SD. SFH: symphysis-fundal height.
Table 3. Incidence of Outcomes of Spinal Anesthesia 
Outcome
Number of parturients 
( N = 52)
Incidence
%
General anesthesia
Respiratory depression
Hypotension
Nausea/vomiting
Fentanyl 80 µg
Postoperative pruritus
Spinal sensory level
  T4
  T5
  T6
0
0
28
17
6
1
24
2
26
0
0
53.8
32.7
11.5
    0.02
46.2
  3.8
50.0176 www.ekja.org
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the correlation was not significant. However, as the maximum 
sensory blockade level increased, the administrated ephedrine 
dose increased and showed significance (P value 0.045) (Table 4).
    A significant correlation was found between the ephedrine 
dose and the SFH when hypotension, nausea and vomiting 
occurred after the spinal anesthesia (Fig. 2). In addition, a 
significant correlation was found between the administrated 
ephedrine dose and the weight of the fetus (Fig. 3). The SFH 
was more strongly correlated with the administrated ephedrine 
dose than the weight of the fetus, which was described by the 
coefficient of determination of the SFH, (25%) (Table 5).
Discussion
    Factors that affect the anesthesia level of spinal anesthesia 
include the properties of cerebrospinal fluid, characteristics 
of the patient, the injection method and the properties of the 
local anesthetic. Among these factors, the height of the patient 
has been recognized as a factor that is strongly related to the 
diffusion of local anesthesia in the subarachnoid space, and 
many anesthetists actually carry out spinal anesthesia using 
different doses of local anesthetic depending on the height of 
the patients. There are many studies regarding whether the 
height and weight of parturient women who undergo Cesarean 
section are correlated with the level of anesthesia. Norris [4,6] 
reported that no correlation was found among the height and 
weight and the level of anesthesia when spinal anesthesia with 
0.75% hyperbaric bupivacaine was used for parturient women. 
Hartwell et al. [7] also reported that when spinal anesthesia 
was performed with 0.75% hyperbaric bupivacaine, no 
correlation was found between the height and the level of spinal 
anesthesia, but a correlation was found between the length of 
the spine and the level of anesthesia. It is known that one of 
the causes of high spinal anesthesia, in addition to the height 
and weight of the parturient women, is that the lumbosacral 
subarachnoidal space volume is decreased as the plexus 
venosus collateral circulation is developed in the epidural 
space by the hypertrophic uterus [2,3]. Thus, we conducted this 
study considering that the SFH, which is an objective indicator 
of the uterus size measurement, may reasonably be a factor 
influencing high spinal anesthesia.
    Hallworth et al. [8] reported that the specific gravity of a 
local anesthetic and the body position, significantly affect 
the occurrence of hypotension during spinal anesthesia in 
parturient women. To exclude the effect of the specific gravity 
of local anesthetic and the body position in this study, we 
Fig. 2. Relationship between total administered dose of ephedrine 
and symphysis-fundal height (SFH) after spinal anesthesia in 52 term 
parturients. It shows that regression coefficient is 2.06 and P value is 
0.0002.
Table 4. Correlation between Spinal Sensory Level and Bupivacaine 
Dose, SFH, Ephedrine Dose
Correlation coefficient P
0.5% hyperbaric bupivacaine
 dose (mg)
SFH (cm)
Ephedrine (mg)
    0.274
-0.195
-0.404
0.059
0.165
  0.045*
SFH: symphysis-fundal height. *P < 0.05 compared with spinal 
sensory level and ephedrine dose.
Fig. 3. Relationship between total administered dose of ephedrine 
and baby weight after spinal anesthesia in 52 term parturients. 
Illustrates that regression coefficient is 0.0082 and P value is 0.0136.
Table 5. Relationship between Total Dose of Ephedrine and SFH, 
Baby Weight
r
2 p a b
SFH (cm)
Baby weight (g)
0.2508
0.1157
0.0002
0.0136
2.0589
0.0082
-74.0439
-19.2529
SFH: symphysis-fundal height, p: P value, r
2: coefficient of deter-
mination, a: correlation coefficient, b: intercept.177 www.ekja.org
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employed one specific gravity and one kind of local anesthetic, 
and the body position of the parturient women was maintained 
as horizontal, except when it was tilted to the left by 15
o to 
prevent supine hypotensive syndrome immediately after the 
spinal anesthesia [9].
    The amount of fluid administrated in advance should be 
considered as a factor that can affect the maximum sensory 
blockade level and occurrence of hypotension. Shin et al. [10] 
reported that the crystalloid solution rapidly injected before 
the spinal anesthesia converted the flow of the cerebrospinal 
fluid to the direction of the lumbar region and consequently 
decreased the diffusion of the local anesthesia toward the 
cephalic region. In order to exclude difference in the maximum 
sensory blockade level and the hypotension incidents resulting 
from the amount of fluid administrated in advance, the 
Hartmann crystalloid solution (15 ml/kg) was injected for 20 
minutes prior to the anesthesia, in the same manner, to all the 
target parturient women in this study, and the blood pressure 
measured after the injection was considered as the reference 
value. Tuominen et al. [11] reported that the injection rate 
of 0.5% plain bupivacaine affected the diffusion of the local 
anesthetic in spinal anesthesia. In this study, we injected the 
drug in all the parturient women at the rate of 0.1 ml/sec, to 
exclude differences in the level of the spinal anesthesia caused 
by the injection rate. 
    Danelli et al. [12] studied the optimum dose of 0.5% hyper-
baric bupivacaine for the Cesarean section of parturient women 
and reported that a dose of ~9.5-10.5 mg was effective for 
95% of the parturient women. They also reported that 10 mg 
was the minimum dose to maintain appropriate anesthesia, 
but hypotension was found in 65% of the patients in the case. 
In this study, the dose of the local anesthetic was determined 
using the table suggested by Harten et al. [5] in order to exclude 
the variations by height and weight. Since Lee et al. [13] 
reported that hypotension was reduced when administering 
the ephedrine dose suggested by Harten et al. [5] in comparison 
to administering a fixed dose to Korean parturient women, 
we thought that the method of Harten et al. [5], that considers 
the height and weight of the parturient women for spinal 
anesthesia, might be more appropriate.
    Oh and Hong [14] reported that the addition of fentanyl 
could reduce the dose of the local anesthesia and hypotension 
incidents, while providing appropriate anesthesia for the 
operation. Although we applied the local anesthetic dose 
suggested by Harten et al. [5] in this study, we used fentanyl (20 
μg), whereas diamorphine (0.4 mg) was used in the study of 
Harten et al. [5]. The average bupivacaine dose used was about 
9.5 mg, which was 0.5 mg less than the dose used by Danelli 
et al. [12]. Ephedrine was administrated in 53.8% of the cases, 
which was similar to 56.8% in the study of Harten et al. [5]. 
    Hypotension is the most common side effect found at the 
anesthesia region after Cesarean section. The causes of nausea 
and vomiting include cerebral ischemia by blood pressure 
drop, hyperfunction of the vagus nerve, intraoperative intestine 
traction, and preanesthetic administration. When hypotension, 
nausea, and vomiting occurred after the spinal anesthesia in 
this study, ephedrine was administrated to treat the nausea 
and vomiting accompanying hypotension. In the study of Kol 
et al. [15], it was reported that the incident of hypotension, as 
well as the incident of nausea and vomiting, was effectively 
reduced in the group of parturient women to whom ephedrine 
was administrated during the spinal anesthesia for Cesarean 
section. Since all nausea and vomiting cases were accompanied 
by hypotension, blood pressure drop was presumably the cause 
of the nausea and vomiting that took place after the spinal 
anesthesia and during the operation.
    Higuchi et al. [3] reported that the density and volume of 
the cerebrospinal fluid affects the diffusion of local anesthetic 
during spinal anesthesia. They also reported that the sensory 
blockade level was elevated and the duration of motor blockade 
action was shortened as the cerebrospinal fluid was less. In 
the case of parturient women, the diffusion of local anesthetic 
toward the direction of the cranial cavity can be enhanced by 
pressure on the inferior vena cava by the hypertrophic uterus, 
shrinkage of the subarachnoid space by the expansion of the 
lumbar vein and vertebral artery around the spinal cavity, 
and the reduction of cerebrospinal fluid [2,3]. The SFH was 
measured in this study to calculate the actual size of the uterus, 
and was done by doctors in the obstetrics and gynecology 
department. To exclude the variations resulting from 
measurement by different individuals, one single examiner 
measured the SFH and the data were not provided to the 
anesthetist. However, contrary to our expectation, the SFH did 
not show a significant correlation with the maximum sensory 
blockade level in this study. Kim et al. [16] also reported that 
the SFH and the cerebrospinal pressure were not significantly 
correlated with the sensory blockade level. In this study, 
however, it was found that the weight of the fetus and the SFH 
were significantly correlated with the amount of ephedrine 
administrated for hypotension. In particular, it was found 
that the SFH was more strongly correlated with the amount 
of administrated ephedrine than with the weight of the fetus. 
This may be because the amount of ephedrine administrated 
for hypotension after the spinal anesthesia was increased as 
the SFH was higher, since the aortic vein was more strongly 
pressed when the SFH was higher. In this study, the table was 
tilted by 15
o to the left to prevent supine hypotensive syndrome, 
but according to Bravema [17], there are some cases where the 
wedge under the right hip should be heightened by about 30
o if 
the uterus is large, because of plural pregnancy or hydramnion. 178 www.ekja.org
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Hence, in the case of a large uterus, careful attention needs 
to be paid to prevent hypotension, by avoiding the aortic vein 
pressure. In addition, research needs to be conducted to study 
the degree of aortic vein pressure according to the size of the 
uterus.
    Although a hypertrophic uterus is usually because of the fetus, 
except in the cases of hydramnion, uterine myoma, or uterine 
anomaly, the size of the uterus may vary depending on the 
amount of amniotic fluid. Thus, the determination coefficient of 
the weight of the newborn baby is smaller than that of the SFH. 
In this study, the SFH was more strongly correlated with the 
amount of ephedrine administrated for hypotension than with 
the weight of the newborn baby.
    In conclusion, although the SFH was not correlated with the 
maximum sensory blockade during the spinal anesthesia for 
Cesarean section, it was correlated with the amount of ephe-
drine administrated for hypotension, which may be correlated 
with the aortic vein pressure. Increasing the gradient of the left 
anterior region of the uterus is also needed to prevent hypo-
tension if the size of the uterus is large.
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